For nearly two decades, we have been pioneers in the field of immunology, pursuing breakthrough science and using high quality manufacturing to deliver best-in-class medicines for patients who need them most. Today we stand on a strong foundation anchored in immunology, with many years of experience. Building on the strength of this foundation, we are forging ahead with a portfolio of next-generation treatments in our pipeline.opens in a new window

Our goal is to transform the way cancer is treated, allowing patients to achieve better and longer-lasting results. We are investing in new pathways, technologies and approaches to tackle the most widespread and debilitating cancers including chronic lymphocytic leukaemia.opens in a new window

We are building on the promise of emerging science, focused on finding solutions for some of the most difficult-to-treat diseases of the brain and nervous system, including Parkinson’s Disease.opens in a new window

Building on our long experience fighting HIV, AbbVie has advanced science and medicine to help address unmet needs across the world for people living with hepatitis C.opens in a new window